Low Dose Naltrexone. An Update from Linda Elsegood, LDN Research Trust

Thinking about LDN (low dose naltrexone)?

Want to know more?

This podcast is for you!

On Monday, April 18, 2016 Dr. Jess Armine has the great pleasure, once again, to interview the creator of the LDN Research Trust, Linda Elsegood!

Diagnosed with Relapsing/Remitting MS in August 2000 at the age of 44, Linda was told that she had Secondary Progressive and there was nothing anyone could do to help. She decided to take matters into her own hands, and started LDN in December 2003.  LDN  helped her with fatigue, restless legs, bladder, bowel, burning legs, leg strength, tingling in feet, sleeping and 'fog in the head'. She now has a better quality of life and hope for the future.

As a result of her amazing improvement, this indefatigueable and loving individual created the LDN Research Trust which disseminates information about LDN throughout the world and empowers people to speak with their doctors about LDN and empowers healthcare providers with information about this vital substance. She takes no money whatsoever. (www.ldnresearchtrust.org) 

In this prerecorded interview (she is in UK), Linda will update us on all the research concerning low-dose naltrexone (LDN) including the benefit of LDN in cases of autoimmune diseases, posttraumatic stress disorder, Crohn's disease, MS, autism, autism spectrum disorders, chronic fatigue, CFS/ME and cancer.

She will introduce the new book about LDN that is presently available on Amazon worldwide (search for "The LDN Book").

Join us and learn from this facinating and dynamic woman!  See you then!  Dr. Jess.